Skip to main content
. Author manuscript; available in PMC: 2013 Apr 7.
Published in final edited form as: Hum Mutat. 2012 Apr;33(4):728–740. doi: 10.1002/humu.22037

Table 4.

Summary of features in individuals with 12p12.1 abnormalities in current cohort and in the literature.

SOX5-only abnormalitiesa Large deletions in this reportb Moleculary characterized deletions in the literaturec Cytogenetically defined 12p12.1 deletionsd
Short stature 1/8 1/7 3/3 5/8
Failure to thrive/low weight 3/9 1/7 1/3 9/9
Microcephaly 2/8 2/7 1/1 6/8
Developmental delay/intellectual disability 9/9 7/7 3/3 9/9
Speech delay 8/9 5/5 3/3 5/6
Behavior problems 5/9 5/5 0/2 1/7
Brain abnormalities 2/5 4/5 1/2 1/2
Hypotonia 4/8 4/7 0/3 3/9
Seizures 2/9 1/7 0/4 1/9
Optic nerve atrophy 0/9 1/7 0/3 2/9
Strabismus 6/9 2/7 0/3 3/9
Abnormal hearing/auditory canals 0/9 1/7 1/3 2/9
Dysmorphic features 6/9 6/7 3/4 9/9
Frontal bossing 4/9 1/7 0/4 1/9
Blue sclerae 1/9 1/7 0/4 1/9
Abnormal nasal bridge 2/9 2/7 3/4 4/9
Low-set ears 0/9 1/7 3/4 6/9
Micro/retrognathia 1/9 0/7 1/4 9/9
Cleft lip and/or palate 0/9 0/7 2/4 0/9
Short/broad neck 0/9 0/7 1/4 3/9
Sparse or abnormal hair 0/9 1/7 1/4 2/9
Irregular teeth/oligodontia 0/9 1/7 1/3 4/9
Brachydactyly 0/9 2/7 2/4 5/9
Clinodactyly/deviated fingers or toes 1/9 4/7 2/4 5/9
Craniosynostosis 0/9 1/7 0/4 2/9
Spinal abnormalities 1/9 1/7 0/4 0/9
Scoliosis 2/9 1/7 0/4 2/9
Other skeletal anomalies 2/9 4/7 3/4 4/9
Congenital heart defects 1/9 1/7 2/4 3/9
Genital abnormalities 2/9 0/7 0/4 3/9
Renal abnormalities 0/9 0/7 2/4 1/9
a

Subjects 1–9 in this study.

b

Subjects 10–16 in this study.

c

Probands with SOX5-containing deletions reported in (Bahring et al., 1997; Glaser et al., 2003; Lu et al., 2009; Nagai et al., 1995; Stumm et al., 2007).